PLSEPulse Biosciences, Inc.

Nasdaq pulsebiosciences.com


$ 14.35 $ 0.85 (6.3 %)    

Tuesday, 04-Jun-2024 15:01:09 EDT
QQQ $ 454.82 $ 1.21 (0.27 %)
DIA $ 398.57 $ 2.11 (0.55 %)
SPY $ 530.36 $ 0.88 (0.17 %)
TLT $ 91.26 $ 0.33 (0.36 %)
GLD $ 225.37 $ -0.89 (-0.41 %)
$ 13.59
$ 13.49
$ 14.21 x 100
$ 14.40 x 300
$ 13.29 - $ 14.92
$ 3.78 - $ 13.88
575,698
na
750.51M
$ 0.89
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-31-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-16-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-03-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-31-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-08-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-20-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-10-2016 06-30-2016 10-Q
33 06-27-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 pulse-biosciences-announces-commencement-of-rights-offering-of-up-to-60m-of-units

Pulse Biosciences, Inc. (NASDAQ:PLSE) (the "Company" or "Pulse Biosciences"), a company leveraging its novel an...

 pulse-biosciences-cellfx-nanosecond-pulsed-field-ablation-technology-will-be-featured-in-several-presentations-at-the-hrs-2024-annual-meeting

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™...

 pulse-biosciences-appoints-burke-t-barrett-as-president-and-chief-executive-officer-former-president-and-ceo-kevin-danahy-appointed-as-chief-commercial-officer

Appoints proven atrial fibrillation medical technology leader Burke T. Barrett as President and Chief Executive OfficerFormer P...

 why-nuvve-holding-shares-are-trading-lower-by-around-30-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Nuvve Holding Corp. (NASDAQ: NVVE) fell sharply during Monday’s session after the company reported worse-than-expect...

 oxford-industries-pvh-and-3-stocks-to-watch-heading-into-monday

With U.S. stock futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as fol...

 pulse-biosciences-q4-eps-022-up-from-025-yoy

Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(...

 pulse-biosciences-board-unanimously-approves-plan-to-initiate-rights-offering-of-up-to-60m-worth-of-units

Robert Duggan, the Company's Executive Chairman and majority stockholder, has indicated his support for the rights offering...

 earnings-scheduled-for-march-28-2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

 why-mesoblast-shares-are-trading-higher-by-13-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an ...

 pulse-biosciences-announces-fda-5-clearance-for-cellfx-nspfa-percutaneous-electrode-system

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217439

 pulse-biosciences-announces-60-day-follow-up-evaluations-for-initial-patients-treated-in-the-cellfx-nspfa-360-cardiac-catheter-first-in-human-feasibility-study

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company with a primary focus on leveraging its novel and proprietary CellFX Nanosecond...

 rivian-automotive-reports-weak-delivery-figures-joins-joyy-mimedx-group-and-other-big-stocks-moving-lower-on-tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

 pulse-biosciences-files-510k-submission-with-us-fda-for-its-cellfx-nspfa-cardiac-clamp

Pulse Biosciences, Inc. (NASDAQ:PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pu...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION